Cargando…
A Rare Case of Hydrochlorothiazide-Induced Hemolytic Anemia
Drug-induced immune hemolytic anemia is an exceedingly rare adverse drug event. Thiazide diuretics, commonly used in the treatment of primary hypertension, have been associated with this complication. In this case report, we present a 77-year-old male who developed acute hemolytic anemia two days af...
Autores principales: | Stevens-Cohen, Pilar, Zaghi, Fardad, Zhu, Lawrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464019/ https://www.ncbi.nlm.nih.gov/pubmed/34589357 http://dx.doi.org/10.7759/cureus.17453 |
Ejemplares similares
-
A Case of Hemolytic Anemia With Acute Myocarditis and Cardiogenic Shock: A Rare Presentation of COVID-19
por: Singhavi, Ravi, et al.
Publicado: (2020) -
Hemolytic Anemia: Sneaky Cause, Leaky Valve
por: Rai, Maitreyee, et al.
Publicado: (2020) -
Comparison of the Effectiveness and Safety of Chlorthalidone and Hydrochlorothiazide in Patients With Hypertension: A Meta-Analysis
por: Khenhrani, Raja Ram, et al.
Publicado: (2023) -
Time Does Not Heal All Ills: The Late Occurrence of Hemolytic Anemia After Prosthetic Mitral Valve Replacement
por: Kaur, Preetraj, et al.
Publicado: (2022) -
Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis
por: Kumar, Lakshya, et al.
Publicado: (2023)